Acquisition / mergerFiled on BSE ·
Bajaj Healthcare Limited received NCLT approval for acquisition of Genrx Pharmaceuticals
Bajaj Healthcare Ltd · Pharmaceuticals & Biotechnology
What the filing says
- NCLT Mumbai Bench approved acquisition of Genrx Pharmaceuticals Private Limited in Liquidation on a going concern basis via order dated October 13, 2026
- Genrx Pharmaceuticals will become a wholly owned subsidiary of Bajaj Healthcare Limited as per NCLT terms
- Trading window for designated persons will remain closed following SEBI insider trading regulations and company policy
Original filing
Announcement Under Regulation 30 Of The SEBI (LODR) Regulations, 2015
Read the filing on BSE (PDF) →Companies guiding to strong growth
Ranked by management's own guidance on revenue and margins — not by us.
Revenue growth 40%+Margin up 2%+
Sign up free to see all 6 →
See full rankingsRank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.
More from Bajaj Healthcare Ltd
- Acquisition / mergerBajaj Healthcare Limited announces unaudited Q2 and H1 FY2026-27 financial results
- Financial resultsBajaj Healthcare Ltd announces unaudited Q2 & H1 FY27 financial results and key updates
- Acquisition / mergerBajaj Healthcare reports Q2 & H1 FY27 results with revenue and profit growth
Other acquisition / merger filings this fortnight
- Acquisition / mergerKPI Green Energy LtdKPI Green Energy’s subsidiary Sun Drops Energia acquires 88.37% stake in DMGEL
- Acquisition / mergerZen Technologies LtdZen Technologies to acquire 51.98% stake in Cogknit Semantics for ₹135.15 crore
- Acquisition / mergerJSW Steel LtdJSW Steel Limited announces NCLT sanction of Scheme of Amalgamation with Piombino Steel Limited
- Acquisition / mergerAdvent Hotels International LtdAdvent Hotels International acquires remaining 25% stake in BD&P Hotels, making it a wholly owned subsidiary
- Acquisition / mergerGFL LtdGFL Limited receives certified order for merger with INOX Infrastructure Limited
- Acquisition / mergerHindware Home Innovation LtdHindware Home Innovation Limited announces NCLT sanction of Composite Scheme
Summary written by Arthneeti from the company's filing with the stock exchange; check the original filing for full details. Arthneeti is a research and analytics platform, not a SEBI-registered investment adviser, and nothing here is a recommendation to buy or sell.